A multicenter trial of cytarabine plus idarubicin or daunorubicin as induction therapy for adult nonlymphocytic leukemia.

Source:http://linkedlifedata.com/resource/pubmed/id/2928807

Download in:

View as

Triples

General Info

PMID
2928807